Parenteral buprenorphine-naloxone abuse is a major cause of fatal buprenorphine-related poisoning – Häkkinen M, Heikman P, Ojanperä I.

by on October 1, 2013

Buprenorphine (BPN) medication for opioid maintenance treatment in Finland consists predominantly of buprenorphine-naloxone (BNX). Both BPN and BNX are associated with diversion, abuse and non-medically supervised use worldwide. Our purpose was to estimate… (Source: SafetyLit: All (Unduplicated))

MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the latest addiction news and research.

Previous post:

Next post: